Ending TB in the Last Frontier

Application deadline: November 2, 2018

Enrollment is limited and pre-registration is required. To apply, please click the Apply button at the bottom of this screen. Note that you will be asked to log in if you haven't already done so. Applicants will be informed of their registration status on a rolling basis.

Cost: There is no fee for this training.

Credit: This training is approved for up to 4.00 continuing education hours (see below). Certificates will be available approximately 12 weeks after the training.

Target audience: This training is intended for physicians, nurses, and healthcare workers providing TB screening and treatment.

Topics covered include:

• Identification of high-risk populations for targeted TB screening
• Interpretation and use of IGRAs for diagnostic testing
• LTBI treatment options, including shorter course use of rifampin and 3HP

Training objectives:
By the end of the training, participants will be able to:

1. identify key populations at risk for tuberculosis infection and tuberculosis disease based on current epidemiological data to inform the prioritization of populations for testing and treatment in the U.S.
2. describe recent trends in TB burden in Alaska to improve patient outcomes.
3. identify at least 3 groups who are at risk for tuberculosis and should undergo screening to prevent tuberculosis disease and transmission
4. discuss pros and cons for the tuberculosis skin tests (TSTs) versus interferon-gamma release assays (IGRAs) and how they may apply to different risk groups to improve application in clinical practice
5. list four recommended treatment options for latent tuberculosis infection (LTBI) and describe the advantages versus disadvantages to each to inform clinical judgment in choosing the optimum regimen for patient care
6. apply new knowledge on tuberculosis risk assessment, diagnostic tools, and treatment options to case scenarios to improve clinical reasoning skills for proper care and management of LTBI
7. identify resources that will aid in tuberculosis control and to improve patient outcomes

Training format: Includes lecture, discussion, and case presentations.

.

The Curry International Tuberculosis Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This training is approved for up to 4.00 continuing education hours.

The Curry International Tuberculosis Center designates this educational activity for a maximum of 4.00 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The Curry International Tuberculosis Center is approved as a provider of continuing education by the California State Board of Registered Nurses, Provider Number CEP 12308. This training is approved for up to 4.00 continuing education hours. Board requirements prevent us from offering CE credit to people who arrive more than 15 minutes after the start of the training, or leave the training early. Therefore, partial credit will not be awarded.

.

The Curry International Tuberculosis Center is designated as a Tuberculosis Center of Excellence for Training, Education, and Medical Consultation (TB COE) via a funded cooperative agreement with the Centers for Disease Control and Prevention. The Curry International Tuberculosis Center prioritizes learners from the western region of the United States which consists of seventeen jurisdictions: Alaska, Arizona, California (including Los Angeles, San Diego, and San Francisco), Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, Wyoming, and the U.S. Pacific Island Territories.

.

Important:

In order for your application to be successfully submitted, you must complete the questions on the enrollment form, which will appear after you click the Apply button. Please do NOT click the back arrow button or close the window, otherwise your access to the questions will be closed. Completion of these questions is required for your application to be considered for acceptance.

.